ArticleBMC cancer2024

Effectiveness of sorafenib in treating intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization.

Reham Ashour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.